Didier Esquieu

477 total citations
12 papers, 398 citations indexed

About

Didier Esquieu is a scholar working on Virology, Molecular Biology and Immunology. According to data from OpenAlex, Didier Esquieu has authored 12 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 7 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Didier Esquieu's work include HIV Research and Treatment (10 papers), Virology and Viral Diseases (3 papers) and HIV/AIDS drug development and treatment (3 papers). Didier Esquieu is often cited by papers focused on HIV Research and Treatment (10 papers), Virology and Viral Diseases (3 papers) and HIV/AIDS drug development and treatment (3 papers). Didier Esquieu collaborates with scholars based in France, United Kingdom and Uganda. Didier Esquieu's co-authors include Erwann Loret, Grant R. Campbell, Sandrine Opi, Jennifer Watkins, Jean‐Marie Péloponèse, Diane Braguer, Vincent Peyrot, Catherine Grégoire, David Yirrell and Eddy Pasquier and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Vaccine.

In The Last Decade

Didier Esquieu

12 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didier Esquieu France 11 297 223 109 68 65 12 398
Amelia Still United States 9 232 0.8× 320 1.4× 44 0.4× 119 1.8× 63 1.0× 10 523
Karsten Bruns Germany 13 196 0.7× 381 1.7× 174 1.6× 117 1.7× 228 3.5× 17 641
Jerrod A. Poe United States 8 156 0.5× 295 1.3× 48 0.4× 107 1.6× 46 0.7× 8 446
Emmanuel Agbottah United States 17 379 1.3× 343 1.5× 166 1.5× 227 3.3× 85 1.3× 19 624
R. M. VALERIO Australia 9 303 1.0× 432 1.9× 124 1.1× 106 1.6× 48 0.7× 11 650
Lihong Zhou United Kingdom 11 167 0.6× 319 1.4× 35 0.3× 122 1.8× 64 1.0× 24 503
Eri Takeda Japan 13 154 0.5× 179 0.8× 146 1.3× 65 1.0× 67 1.0× 25 437
Alok Mulky United States 9 184 0.6× 232 1.0× 46 0.4× 127 1.9× 49 0.8× 10 375
Lillian S. Kuo United States 10 197 0.7× 145 0.7× 72 0.7× 113 1.7× 42 0.6× 12 341
Bhaskar Chandrasekhar United States 6 284 1.0× 209 0.9× 262 2.4× 69 1.0× 43 0.7× 9 519

Countries citing papers authored by Didier Esquieu

Since Specialization
Citations

This map shows the geographic impact of Didier Esquieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Esquieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Esquieu more than expected).

Fields of papers citing papers by Didier Esquieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Esquieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Esquieu. The network helps show where Didier Esquieu may publish in the future.

Co-authorship network of co-authors of Didier Esquieu

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Esquieu. A scholar is included among the top collaborators of Didier Esquieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Esquieu. Didier Esquieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Campbell, Grant R., Jennifer Watkins, Didier Esquieu, et al.. (2007). Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties. Vaccine. 25(50). 8441–8447. 11 indexed citations
2.
Makarov, Alexander А., Philipp O. Tsvetkov, Claude Villard, et al.. (2007). Vinflunine, a Novel Microtubule Inhibitor, Suppresses Calmodulin Interaction with the Microtubule-Associated Protein STOP. Biochemistry. 46(51). 14899–14906. 29 indexed citations
3.
Watkins, Jennifer, Sophie Lancelot, Grant R. Campbell, et al.. (2006). Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. Retrovirology. 3(1). 8–8. 22 indexed citations
4.
Campbell, Grant R., Jennifer Watkins, Didier Esquieu, et al.. (2005). The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T Cells. Journal of Biological Chemistry. 280(46). 38376–38382. 35 indexed citations
5.
Carré, Manon, Pascale Barbier, Grant R. Campbell, et al.. (2005). HIV-1 Tat protein enhances Microtubule polymerization. Retrovirology. 2(1). 5–5. 48 indexed citations
6.
Opi, Sandrine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2004). Full-length HIV-1 Tat protein necessary for a vaccine. Vaccine. 22(23-24). 3105–3111. 22 indexed citations
7.
Vo‐Thanh, Giang, Valérie Fargeas, Didier Dubreuil, et al.. (2004). A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor. Bioorganic & Medicinal Chemistry Letters. 14(6). 1543–1546. 10 indexed citations
8.
Campbell, Grant R., Eddy Pasquier, Jennifer Watkins, et al.. (2004). The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis. Journal of Biological Chemistry. 279(46). 48197–48204. 76 indexed citations
9.
Esquieu, Didier, Jean‐Marie Péloponèse, Sandrine Opi, et al.. (2003). Discovery of a Tat HIV‐1 Inhibitor through Computer‐Aided Drug Design. Journal of Spectroscopy. 17(4). 639–645. 6 indexed citations
10.
Opi, Sandrine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2002). Tat HIV-1 Primary and Tertiary Structures Critical to Immune Response Against Non-homologous Variants. Journal of Biological Chemistry. 277(39). 35915–35919. 34 indexed citations
11.
Grégoire, Catherine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2001). Homonuclear 1H‐NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers. 62(6). 324–335. 42 indexed citations
12.
Péloponèse, Jean‐Marie, Catherine Grégoire, Sandrine Opi, et al.. (2000). 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 323(10). 883–894. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amelia Still Breakdown of academic impact, for papers by Karsten Bruns Breakdown of academic impact, for papers by Jerrod A. Poe Breakdown of academic impact, for papers by Emmanuel Agbottah Breakdown of academic impact, for papers by R. M. VALERIO Breakdown of academic impact, for papers by Lihong Zhou Breakdown of academic impact, for papers by Eri Takeda Breakdown of academic impact, for papers by Alok Mulky Breakdown of academic impact, for papers by Lillian S. Kuo Breakdown of academic impact, for papers by Bhaskar Chandrasekhar
Rankless by CCL
2026